Do people with type 2 diabetes find continuous and intermittent low-energy diets for weight loss and diabetes remission acceptable?
Name:
Do people with type 2 diabetes ...
Size:
666.1Kb
Format:
PDF
Description:
Found with Open Access Button
Affiliation
Division of Cancer Sciences, University of Manchester, Manchester, UK. Manchester Cancer Research Centre, Manchester, UK.Issue Date
2024
Metadata
Show full item recordAbstract
BACKGROUND: The Manchester Intermittent versus Daily Diet App Study (MIDDAS) tested the feasibility and potential efficacy of two remotely delivered low-energy diet (LED) programmes (800 kcal/day) to support weight loss and remission of type 2 diabetes: continuous [CLED] (8 weeks of daily LED) and intermittent [ILED] (2 days of LED/week for 28 weeks). Understanding participant experiences can help us to understand the acceptability of LED programmes to people with type 2 diabetes, informing future programme development and implementation. METHODS: Twenty participants (10 CLED; 10 ILED) took part in interviews conducted at the end of the active weight loss phase (CLED week 12, ILED week 28). Interviews were transcribed and analysed thematically using the template analysis approach, with an a priori focus on acceptability. Four themes are presented: prospective acceptability, intervention coherence and perceived effectiveness, opportunity costs and self-efficacy. RESULTS: Both remotely supported CLED and ILED interventions appeared acceptable to participants. CLED participants found the rapid initial weight loss phase comparatively easy and highly motivating but expressed more concerns around weight maintenance. ILED participants found the more gradual weight loss initially frustrating but expressed greater confidence in their longer-term adherence. The importance of continued individualised support from healthcare professionals was emphasised, and evidence of weight loss and improvement in other medical markers through monitoring via the mobile phone app was useful. CONCLUSION: Different approaches to remotely delivered LEDs appear acceptable; therefore asking patients which approach may be more acceptable to them may be a useful way to offer individualised and tailored support.Citation
Brooks J, Ruane H, McDiarmid S, Vyas A, Issa B, Harvie M. Do people with type 2 diabetes find continuous and intermittent low-energy diets for weight loss and diabetes remission acceptable? Journal of human nutrition and dietetics : the official journal of the British Dietetic Association. 2024 May 27. PubMed PMID: 38798236. Epub 2024/05/27. eng.Journal
Journal of Human Nutrition and DieteticsDOI
10.1111/jhn.13313PubMed ID
38798236Additional Links
https://dx.doi.org/10.1111/jhn.13313Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1111/jhn.13313
Scopus Count
Collections
Related articles
- Intermittent Versus Continuous Low-Energy Diet in Patients With Type 2 Diabetes: Protocol for a Pilot Randomized Controlled Trial.
- Authors: McDiarmid S, Harvie M, Johnson R, Vyas A, Aglan A, Moran J, Ruane H, Hulme A, Sellers K, Issa B
- Issue date: 2021 Mar 19
- Manchester Intermittent versus Daily Diet App Study (MIDDAS): A pilot randomized controlled trial in patients with type 2 diabetes.
- Authors: McDiarmid S, Harvie M, Johnson R, Vyas A, Aglan A, Moran J, Ruane H, Hulme A, Sellers K, Issa BG
- Issue date: 2022 Mar
- Manchester Intermittent and Daily diet Type 1 Diabetes App Study (MIDDAS-Type 1): protocol for a randomised feasibility trial of an intermittent and continuous low-energy diet in patients with type 1 diabetes and overweight and obesity.
- Authors: McDiarmid S, Harvie M, Aglan A, Winterbottom H, Mubita W, Hulme A, Davies J, Yates J, Krizak S, Perry D, Issa BG
- Issue date: 2023 Jul 20
- Participant experiences in the Diabetes REmission Clinical Trial (DiRECT).
- Authors: Rehackova L, Rodrigues AM, Thom G, Brosnahan N, Barnes AC, McCombie L, Leslie WS, Zhyzhneuskaya S, Peters C, Adamson AJ, Lean MEJ, Taylor R, Sniehotta FF
- Issue date: 2022 Jan
- Experiences and Acceptability of a Weight Loss Intervention for Diabetes (Diabetes Remission Clinical Trial-DiRECT) in Aotearoa New Zealand: A Qualitative Study within a Pilot Randomised Controlled Trial.
- Authors: Campbell K, Peddie M, Ashton N, Ma'ia'i K, Russell-Camp T, Mann J, Camp J, Reynolds AN
- Issue date: 2024 Jun 13